4Front Financial Statements From 2010 to 2025
| FFNTF Stock | USD 0.0007 0 65.00% |
Check 4Front Ventures financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among 4Front Ventures' main balance sheet or income statement drivers, such as , as well as many indicators such as . 4Front financial statements analysis is a perfect complement when working with 4Front Ventures Valuation or Volatility modules.
4Front |
4Front Ventures Corp Company Profit Margin Analysis
4Front Ventures' Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current 4Front Ventures Profit Margin | (0.32) % |
Most of 4Front Ventures' fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, 4Front Ventures Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, 4Front Ventures Corp has a Profit Margin of -0.3243%. This is 97.11% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The profit margin for all United States stocks is 74.46% lower than that of the firm.
4Front Ventures Corp Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining 4Front Ventures's current stock value. Our valuation model uses many indicators to compare 4Front Ventures value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across 4Front Ventures competition to find correlations between indicators driving 4Front Ventures's intrinsic value. More Info.4Front Ventures Corp is rated # 5 in return on equity category among its peers. It also is rated # 5 in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the 4Front Ventures' earnings, one of the primary drivers of an investment's value.About 4Front Ventures Financial Statements
4Front Ventures stakeholders use historical fundamental indicators, such as 4Front Ventures' revenue or net income, to determine how well the company is positioned to perform in the future. Although 4Front Ventures investors may analyze each financial statement separately, they are all interrelated. For example, changes in 4Front Ventures' assets and liabilities are reflected in the revenues and expenses on 4Front Ventures' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in 4Front Ventures Corp. Please read more on our technical analysis and fundamental analysis pages.
4Front Ventures Corp. owns and manages licensed cannabis facilities in state-licensed markets in the United States. In addition, the company sells equipment, supplies, and intellectual property to cannabis producers imports and sale equipment and supplies leases real estate properties to cannabis producers offers consulting services and operates cannabis dispensaries. 4Front Ventures Corp. was founded in 2011 and is based in Phoenix, Arizona. 4FRONT VENTURES operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 464 people.
Currently Active Assets on Macroaxis
| IGIB | iShares 5 10 Year | |
| SPTL | SPDR Barclays Long | |
| SCHH | Schwab REIT ETF | |
| SPMB | SPDR Portfolio Mortgage | |
| SPTI | SPDR Portfolio Intermediate |
Other Information on Investing in 4Front Pink Sheet
4Front Ventures financial ratios help investors to determine whether 4Front Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in 4Front with respect to the benefits of owning 4Front Ventures security.